Takeda Pharmaceutical Company Ltd
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- -
- Established
- 1925-01-01
- Employees
- -
- Market Cap
- $47.5B
- Website
- http://www.takeda.co.jp/
A Phase I Clinical Pharmacology Study of TAK-233 in Healthy Subjects
- First Posted Date
- 2014-04-14
- Last Posted Date
- 2014-10-21
- Lead Sponsor
- Takeda
- Target Recruit Count
- 24
- Registration Number
- NCT02113020
A Phase 1/2 Study of a Intramuscular Injection of TAK-850 in Healthy Adult Subjects
- First Posted Date
- 2014-04-11
- Last Posted Date
- 2015-07-27
- Lead Sponsor
- Takeda
- Target Recruit Count
- 55
- Registration Number
- NCT02111252
Sodium Risedronate Tablets - Special Drug Use Surveillance in Patients With Osseous Paget's Disease (All-case Surveillance) -48-week Surveillance -
- First Posted Date
- 2014-04-08
- Last Posted Date
- 2019-06-03
- Lead Sponsor
- Takeda
- Target Recruit Count
- 315
- Registration Number
- NCT02106455
36-month Special Drug Use Surveillance on Frequency of Bone Fractures With Sodium Risedronate 75 mg Tablets
- First Posted Date
- 2014-04-08
- Last Posted Date
- 2019-07-30
- Lead Sponsor
- Takeda
- Target Recruit Count
- 579
- Registration Number
- NCT02106442
Long-term Use of Takepron Capsules on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin
- First Posted Date
- 2014-03-31
- Last Posted Date
- 2016-11-04
- Lead Sponsor
- Takeda
- Target Recruit Count
- 3366
- Registration Number
- NCT02099682
Long-term Use of Takepron on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs
- First Posted Date
- 2014-03-31
- Last Posted Date
- 2016-10-27
- Lead Sponsor
- Takeda
- Target Recruit Count
- 3502
- Registration Number
- NCT02099708
Azilsaltan Tablets (Azilva Tablets) Special Drug Use Surveillance "Hypertension Complicated by Diabetes "
- First Posted Date
- 2014-03-31
- Last Posted Date
- 2019-03-21
- Lead Sponsor
- Takeda
- Target Recruit Count
- 387
- Registration Number
- NCT02100319
Long-term Use of Sonias Combination Tablets in Patients With Type 2 Diabetes Mellitus
Completed
- Conditions
- Type 2 Diabetes
- Interventions
- Drug: Pioglitazone/glimepiride
- First Posted Date
- 2014-03-28
- Last Posted Date
- 2016-04-15
- Lead Sponsor
- Takeda
- Target Recruit Count
- 1168
- Registration Number
- NCT02098733
Pioglitazone/Glimepiride (Sonias) Combination Tablets Special Drug Use Surveillance Survey in Patients With Type 2 Diabetes Mellitus Who Respond Poorly to Pioglitazone
Completed
- Conditions
- Type 2 Diabetes
- Interventions
- Drug: Pioglitazone/glimepiride
- First Posted Date
- 2014-03-28
- Last Posted Date
- 2016-10-18
- Lead Sponsor
- Takeda
- Target Recruit Count
- 294
- Registration Number
- NCT02098746
Sensory Evaluation of Dexlansoprazole Delayed-Release Orally Disintegrating Tablets
Phase 1
Completed
- Conditions
- Gastroesophageal Reflux DiseaseErosive EsophagitisHeartburn
- Interventions
- First Posted Date
- 2014-03-26
- Last Posted Date
- 2015-03-06
- Lead Sponsor
- Takeda
- Target Recruit Count
- 8
- Registration Number
- NCT02096458
© Copyright 2025. All Rights Reserved by MedPath